# ESOMEPRAZOLE MAGNESIUM
> **ANDA217714** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2025-01-07
## Drug
- **FDA Application Number:** ANDA217714
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESOMEPRAZOLE MAGNESIUM
- **Generic name:** ESOMEPRAZOLE MAGNESIUM
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM
- **Dosage form:** FOR SUSPENSION, DELAYED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2025-01-07
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217714)
---
*AI Analytics · CC0 1.0*